MX9710529A - Compuestos terapeuticos. - Google Patents

Compuestos terapeuticos.

Info

Publication number
MX9710529A
MX9710529A MX9710529A MX9710529A MX9710529A MX 9710529 A MX9710529 A MX 9710529A MX 9710529 A MX9710529 A MX 9710529A MX 9710529 A MX9710529 A MX 9710529A MX 9710529 A MX9710529 A MX 9710529A
Authority
MX
Mexico
Prior art keywords
hydrogen
compounds
oac
therapeutic compounds
nhac
Prior art date
Application number
MX9710529A
Other languages
English (en)
Other versions
MXPA97010529A (es
Inventor
Stephen Martin Courtney
Original Assignee
Oxford Glycosciences Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9512868.2A external-priority patent/GB9512868D0/en
Priority claimed from GBGB9608372.0A external-priority patent/GB9608372D0/en
Priority claimed from GBGB9608547.7A external-priority patent/GB9608547D0/en
Application filed by Oxford Glycosciences Uk Ltd filed Critical Oxford Glycosciences Uk Ltd
Publication of MX9710529A publication Critical patent/MX9710529A/es
Publication of MXPA97010529A publication Critical patent/MXPA97010529A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Se describen compuestos de la formula (I), en donde R es halogeno, Y es hidrogeno; NH2, SH u OH; X es (11) en donde cualquiera de R1 o R2 es un enlace, con el otro siendo hidrogeno; cualquiera de R3 o R4 es hidrogeno, con el otro siendo hidrogeno; OH, OAc o NHAc; R5 es OH u OAc; cualquiera de R7 o R8 es hidrogeno, con el otro siendo OH u OAc; Rg es hidrogeno, CH2OH o CH2OAc; con la condicion de que cuando R4 es OH, OAc o NHAc entonces R8 es hidrogeno, y anantiomeros de dichos compuestos. También se proveen formulaciones farmacéuticas que comprenden dichos compuestos, su uso en el tratamiento de varios estados de enfermedad y métodos de tratamiento que emplean los compuestos.
MXPA/A/1997/010529A 1995-06-23 1997-12-19 Compuestos terapeuticos MXPA97010529A (es)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GB9512868.2 1995-06-23
GBGB9512868.2A GB9512868D0 (en) 1995-06-23 1995-06-23 Therapeutic compounds
GBGB9608372.0A GB9608372D0 (en) 1996-04-23 1996-04-23 Therapeutic compounds
GB9608372.0 1996-04-23
GB9608547.7 1996-04-25
GBGB9608547.7A GB9608547D0 (en) 1996-04-25 1996-04-25 Therapeutic compounds
US1676296P 1996-05-03 1996-05-03
US016762 1996-05-03
US1697396P 1996-05-07 1996-05-07
US016973 1996-05-07
PCT/GB1996/001519 WO1997000882A1 (en) 1995-06-23 1996-06-24 Therapeutic compounds

Publications (2)

Publication Number Publication Date
MX9710529A true MX9710529A (es) 1998-08-30
MXPA97010529A MXPA97010529A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
ID16479A (id) 1997-10-02
DE69614867T2 (de) 2002-04-11
KR19990028344A (ko) 1999-04-15
EP0851866A1 (en) 1998-07-08
WO1997000882A1 (en) 1997-01-09
HUP9901438A3 (en) 2000-07-28
US5945406A (en) 1999-08-31
CN1196059A (zh) 1998-10-14
EP0851866B1 (en) 2001-08-29
JPH11507942A (ja) 1999-07-13
IL122700A0 (en) 1998-12-06
NO976043L (no) 1998-02-20
ES2162078T3 (es) 2001-12-16
HUP9901438A2 (hu) 1999-08-30
CA2225247A1 (en) 1997-01-09
AU6234296A (en) 1997-01-22
PL328266A1 (en) 1999-01-18
DE69614867D1 (de) 2001-10-04
ATE204878T1 (de) 2001-09-15
NO976043D0 (no) 1997-12-22

Similar Documents

Publication Publication Date Title
GB9514473D0 (en) Chemical compounds
CA2263561A1 (en) Thienopyrimidines
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
MY108885A (en) Heterocyclic-cyclic amine derivatives.
HU9603469D0 (en) Pyrazolo and pyrrolopyridines
GR3033846T3 (en) Imidazopyridines and their use in treating gastrointestinal diseases.
AP9701041A0 (en) Pyridylpyrrole compounds.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
AU7095587A (en) 1,4-diazepines
GB9418912D0 (en) Pharmaceutically active compounds
PL328266A1 (en) Therapeutic compounds
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
MX9800049A (es) Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso.
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
ES2017279A6 (es) Procedimiento para la obtencion de piperazinas y homopiperazinas substituidas.
ATE247955T1 (de) Selenophen-antitumormittel
DE69321096D1 (de) Katecholamine-diphosphate und diese enthaltende arzneimittel
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
DE3268605D1 (en) 3,7a-diazacyclohepta(j,k)fluorene derivatives, their preparation and therapeutical use
SE9603284D0 (sv) New compounds
GR3019327T3 (en) An imidazobenzodiazepin for treating sleep disorders
NZ519747A (en) Quaternary ammonium and their use as anti-tussive agent
IT1243947B (it) 2-azido-ornitina, sua preparazione e suo impiego in terapia
ZA917273B (en) Use of n-(1-hexahydroazepinylalkyl)acetamides in the preparation of medicaments for the treatment of cholinergic transmission disorders